HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

jozimine A2

isolated from the root bark of an Ancistrocladus species; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Isoquinolines: 34
      - jozimine A2: 2
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        jozimine A2: 2
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - jozimine A2: 2

Experts

1.	Bringmann, Gerhard: 2 articles (11/2019 - 10/2017)
2.	Brun, Reto: 2 articles (11/2019 - 10/2017)
3.	Feineis, Doris: 2 articles (11/2019 - 10/2017)
4.	Kaiser, Marcel: 2 articles (11/2019 - 10/2017)
5.	Li, Jun: 2 articles (11/2019 - 10/2017)
6.	Aké Assi, Laurent: 1 article (11/2019)
7.	Anany, Mohamed A: 1 article (11/2019)
8.	Fayez, Shaimaa: 1 article (11/2019)
9.	Wajant, Harald: 1 article (11/2019)
10.	Awale, Suresh: 1 article (10/2017)

Related Diseases

1.	Pancreatic Neoplasms (Pancreatic Cancer) 10/27/2017 - "Jozilebomines A (1a) and B (1b) and jozimine A2 (2) represent novel potential candidates for future drug development against pancreatic cancer."
2.	Neoplasms (Cancer) 11/22/2019 - "Furthermore, jozimine A2 (1d) showed cytotoxicity against human colon carcinoma (HT-29), fibrosarcoma (HT1080), and multiple myeloma (MM.1S) cancer cells, displaying IC50 values of 12.0, 9.0, and 5.0 μM, respectively, whereas jozibrevines A (1a) and B (1b) were nontoxic in this concentration range."
3.	Multiple Myeloma 11/22/2019 - "Furthermore, jozimine A2 (1d) showed cytotoxicity against human colon carcinoma (HT-29), fibrosarcoma (HT1080), and multiple myeloma (MM.1S) cancer cells, displaying IC50 values of 12.0, 9.0, and 5.0 μM, respectively, whereas jozibrevines A (1a) and B (1b) were nontoxic in this concentration range."
4.	Fibrosarcoma 11/22/2019 - "Furthermore, jozimine A2 (1d) showed cytotoxicity against human colon carcinoma (HT-29), fibrosarcoma (HT1080), and multiple myeloma (MM.1S) cancer cells, displaying IC50 values of 12.0, 9.0, and 5.0 μM, respectively, whereas jozibrevines A (1a) and B (1b) were nontoxic in this concentration range."
5.	Carcinoma (Carcinomatosis) 11/22/2019 - "Furthermore, jozimine A2 (1d) showed cytotoxicity against human colon carcinoma (HT-29), fibrosarcoma (HT1080), and multiple myeloma (MM.1S) cancer cells, displaying IC50 values of 12.0, 9.0, and 5.0 μM, respectively, whereas jozibrevines A (1a) and B (1b) were nontoxic in this concentration range."